Chronic non atrophic gastritis
Conditions
Interventions
Group 1:placebo-controlled
Group 2:low dose
Group 3:High dose
Sponsors
Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, West China School of Medicine, Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Fulfilling the Western Medicine diagnosis of chronic non-atrophic gastritis (chronic inflammation is moderate and above, and / or active inflammation); 2. Fulfilling the TCM diagnosis of spleen and stomach Qi deficiency with damp-heat stasis syndrome; 3. Aged between 18-65 years old; 4. Willing to participate and sign the inform consent.
Exclusion criteria
Exclusion criteria: 1. history of gastric surgery; 2. Combined stomach?duodenum ulcer, special type of gastritis, peptic ulcer, bleeding, gastric mucosa dysplasia or suspected malignant pathologically; 3. pathological examinations showed atrophy and / or intestinal metaplasia lesions; 4. combined cardiovascular, lung, liver, kidney and hematopoietic systems severe primary disease (above NYHA II; ALT, AST 1.5 times of the upper limit of normal; Cr over the upper limit of normal), or diseases which severely affect their survival, such as cancer or AIDS; 5. fecal occult blood is positive; 6. had received other TCM treatment to treat this disease in the last two weeks; 7. mental illness or alcohol / drug abuse history; 8. pregnancy or prepare pregnant women, lactating women; 9. allergies or allergic to the known ingredient of the test drug; 10. participated or are participating in clinical trials by other drugs within the past three months; 11. syndrome differentiation is not clear or there are too many combinations and syndromes; 12. Researchers who consider it's not appropriate to participate in clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| epigastric pain disappearance rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual analogue scale method (VAS) changes before and after treatment;primary treatment effect; | — |
Countries
China
Contacts
Public ContactXia Qing
West China Hospital, West China School of Medicine, Sichuan University
Outcome results
None listed